Israel Englander Incyte Corp Call Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$51.18 - $63.75 $225,192 - $280,500
4,400 New
4,400 $266,000
Q4 2023

Feb 14, 2024
SELL
$52.16 - $64.19 $865,856 - $1.07 Million
-16,600 Reduced 83.0%
3,400 $213,000
Q2 2023

Aug 14, 2023
BUY
$60.95 - $75.51 $1.22 Million - $1.51 Million
20,000 New
20,000 $1.25 Million
Q4 2022

Feb 14, 2023
BUY
$67.18 - $84.11 $1.36 Million - $1.7 Million
20,200 New
20,200 $1.62 Million

Others Institutions Holding INCY

# of Institutions
624
Shares Held
198M
Call Options Held
766K
Put Options Held
476K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email